An opinion post
I once wrote an article called “Neuroendocrine Cancer – can it be cured“. In that article, I covered the fact that most stage IV cancers (all cancers) are generally considered incurable, but I also added my own view of NETs being treatable in the same way a chronic disease would be. At the other end of the scale, I covered guidelines where doctors talk about removing tumours with “curative intent”, clearly in reference to small localized tumour scenarios. I’m pretty sure in my own mind that this does happen. As one example you only need to look at the epidemiology data on (say) small low-grade low-stage appendiceal and rectal NETs; to know that they rarely metastasise/recur, translated into guidelines as needing “no follow up” related to size and margin pathology score. However, in one sentence, “cure” generally means that there are no traces of your cancer after treatment and cancer will never come back. That’s a pretty big statement that seems impossible to predict in every single cancer patient. I guess doctors tread carefully before saying the word ‘cured‘. Epidemiology data plays a big part in decisions on how to guide doctors and manage patient expectations, i.e. based on the data collected over a period of years, doctors are able to assess the likelihood of a recurrence (as inferred above). For some doctors, I suspect they also base this on what they see in their own practices, at least in the larger hospitals seeing hundreds or thousands of patients over a period of time. When I read comments from members of my patient group, the lack of a standard is obvious. Words such as “stable“, “no evidence of disease” and “cancer free” are frequently used. Less quoted are terms such as “remission” or “cured“. I myself am “reassuringly stable” but with “evidence of disease“.
Other than the general cancer definitions I’ve quoted below, there is no real standard for what a doctor should say to a patient at relevant points in their surveillance in terms of the future, this really is not an exact science. I believe it has to be understood that this is really pretty much the way things are and thus why words need to be carefully thought through before being uttered. To a patient, these words are really important, as is the context in which they are said.
For some in the Neuroendocrine patient community, this is both a controversial and emotional subject, understandably so. However, it is not helped by the ‘blanket statements’ continually made about all types of Neuroendocrine Cancer (Neoplasms) when they only really apply to a subset. Neuroendocrine Neoplasms are a heterogenous collection of cancers and this heterogeneity applies in various other ways, not just in the classification of the disease.
What does remission actually mean?
I looked at various sources and they all appear to say the same thing. Most sites you find will say something like this although I have added informed comments from one of my GoTo physician sources who like to add context to the bland statements from national cancer organisations:
Remission means that the signs and symptoms of your cancer are reduced. Remission can be partial or complete.
- Partial remission means the cancer is still there, but your tumour has gotten smaller, or you have less cancer throughout your body. Some doctors tell patients to think of their cancer as “chronic,” (author’s note: and this is relevant to locally advanced or metastatic Neuroendocrine Tumours (NETs). It’s something you may need to continue to check. If you’re in partial remission, it may mean you can take a break from treatment (where applicable) as long as the cancer doesn’t begin to grow again.
- Complete remission means that tests, physical exams, and scans show that all signs of your cancer are gone. Some doctors also refer to complete remission as “no evidence of disease (NED).” However, that doesn’t mean you are cured. Doctors can only make these statements based on their imaging (i.e. what can be seen by imaging) or suggested by other tests. But there is still a chance that cancer will come back later. For this reason, doctors cannot say for sure that you are cured. The most they can say is that there are no signs of cancer at this time (e.g. “No evidence of disease”).
If you remain in complete remission for 5 years* or more, some doctors may discharge you saying you are “cured” but I suspect they mean ‘unlikely to return’ as cancers that return, most do so within the first 5 years after treatment. In scenarios where there is a higher chance of recurrence, your doctor may monitor you for many years and do tests to look for signs of cancer’s return. Hopefully, in that time, they will also look for signs of late side effects from the cancer treatments you received (an area that perhaps needs more attention?).
*Interest point. Some cancer types have smaller or larger periods due to known behaviors. I have heard some NET specialists talking about 10 years and even beyond that with longer surveillance intervals in some cases. My CT scan has recently been extended from 6 months to 12 months due to ‘stable disease’ as one example (diagnosed Stage IV small intestine NET 2010 but with ‘evidence of disease’).
I think it’s worth including this definition as it overlaps with the remission definitions. Some cancer cells can remain unnoticed in the body for years after treatment. If a cancer returns after it has been in remission, it’s called a “recurrence.” Cancer can recur in the same place it was originally diagnosed, or it can recur in a different part of the body. It’s normal to be concerned that this will happen to you. Every situation is different, and there’s no way to predict what will happen.
I mentioned a lot of terms above, but doctors very often use these terms interchangeably. Consequently, it’s important to ask your oncologist or specialist specifically what they mean. Because one doctor may use any of them one way, and another doctor might use them in another context.
I personally think for those with more advanced Neuroendocrine Cancers (i.e. higher stages), as long as you continue to get surveillance, access to therapy (without insurance-based constraints where this is applicable), these terms then become less significant.
Thanks for listening.
I am not a doctor or any form of medical professional, practitioner or counsellor. None of the information on my website, or linked to my website(s), or conveyed by me on any social media or presentation, should be interpreted as medical advice given or advised by me. Neither should any post or comment made by a follower or member of my private group be assumed to be medical advice, even if that person is a healthcare professional as they are not members of the private group or followers of my sites in any official capacity. Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over the counter drugs and supplements such as vitamins and minerals.
Subscribe to my newsletter
Top 10 Posts & Pages in the last 48 hours (auto updates)
Thanks for reading.
Sign up for my newsletters – Click Here
Please Share this post for Neuroendocrine Cancer awareness and to help another patient
On Rare Cancer Day, what’s wrong with a bit of Neuroendocrine Cancer awareness? Well, there are three main things wrong with Neuroendocrine Cancer awareness: 1.
Prospective Phase II Trial of Prognostication by 68Ga-NOTA-AE105 uPAR PET in Patients with Neuroendocrine Neoplasms: Implications for uPAR-Targeted Therapy
Summary A novel PET radiotracer can accurately assess the presence of a biomarker that indicates the level of tumor aggressiveness in neuroendocrine neoplasms (NENs). According
I’m wired not to worry too much about something I cannot control. For example, I automatically ignore any concerns about being inside an imaging device
A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors (MAST)
A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors (MAST) Neuroendocrine
Neuroendocrine Cancer: When you get years added to your life, it’s important to get life added to your years
Self Pity or Self Help? I’m not one for wallowing in self-pity or accepting invites to pity parties. It’s not my style. Things happen in
An opinion post Cure I once wrote an article called “Neuroendocrine Cancer – can it be cured“. In that article, I covered the fact that
What is RYZ101? RYZ101 is an investigational targeted alpha-emitter radiopharmaceutical therapy, designed to deliver a highly potent radioisotope, Actinium-225 (Ac225), to tumors expressing SSTR2. RYZ101
September is Childhood Cancer Awareness Month! The newspapers and social media will no doubt be featuring many children’s cancer articles. I personally cannot begin to